The only variant with evidence level 1 that showed greater MAF in the MxGDAR/Encodat was NUDT15*3 (dMAF = 0.0452), a variant that may increase the risk of leukopenia or neutropenia in those individuals treated with purine compounds (Yang et al., 2014). The gene discussed is NUDT15; the disease is neutropenia.